ACE Incubator

ACE Incubator is a university startup incubator that actively supports researchers, scientists, students and entrepreneurs with tech-driven ideas looking to transform their concepts into a feasible business. ACE is equally owned by 4 acamedic institutions in Amsterdam: UvA, VU, HvA and Amsterdam UMC. Today the incubator is home to young entrepreneurs who develop world changing concepts in industries like Deep-tech, Medical & Health Technology, Chemical & Advanced Materials and Sustainable Technology. Offering tailored programs, startup facilities, entrepreneurial network and mentorship from the best startup experts, ACE supports ambitious science and high-tech entrepreneurs across every stage of starting a business.

Darya Krasilnikov

Director

30 past transactions

Kibo

Pre Seed Round in 2020
Kibo provides unified commerce solutions you can count on for B2C and B2B Ecommerce, Order Management, Personalization, and Point of Sale.

Artexpert

Pre Seed Round in 2020
Art evaluation with AI and blockchain

Lalaland

Pre Seed Round in 2019
Lalaland is a company that specializes in generating artificial full-body fashion models for e-commerce brands, allowing them to showcase their collections on avatars that reflect the diversity of their customer base. Utilizing advanced machine learning techniques, Lalaland's platform creates customized digital avatars representing various ethnicities, ages, and body types. This flexibility enables brands to tailor models to individual preferences, including hairstyles and body shapes for both males and females. By offering a diverse library of AI-generated models, Lalaland aims to enhance conversion rates for fashion retailers while simultaneously reducing product return rates.

Dyme

Pre Seed Round in 2018
Dyme B.V. is a company based in Amsterdam, Netherlands, founded in 2018. It has developed a mobile application that consolidates users' subscriptions, allowing them to manage, cancel, and switch services efficiently. The app serves as a smart savings platform, providing users with a comprehensive overview of their income and expenses. By leveraging financial data and machine learning technologies, Dyme's platform offers insights into personal finances and aids in the renegotiation of ongoing contracts, enabling users to reduce their fixed expenses and save money.

CargoLedger

Pre Seed Round in 2017
CargoLedger is a company focused on transforming the supply chain by leveraging blockchain technology. Its innovative system aims to make supply chain processes paperless, enhance data security, and provide immutable records. By enabling real-time tracking and sharing of information, CargoLedger reduces the need for extensive audits and control measures, thereby increasing efficiency. The platform also facilitates instant settlement and payment, which streamlines financial transactions within the supply chain. Overall, CargoLedger's solutions aim to address and minimize inefficiencies commonly encountered in supply chain operations.

Macrobian Biotech

Pre Seed Round in 2017
Macrobian Biotech focuses on developing innovative treatments for disorders affecting the dopamine system, a critical component of the midbrain involved in various neurological and neuropsychiatric conditions. The company engages in both fundamental and clinical research within the neuroscience field, utilizing advanced technologies in genetics and transcriptomics. By conducting extensive gene function research, Macrobian Biotech equips healthcare practitioners with compounds that are ready for clinical trials, aiming to address unmet medical needs in the treatment of these complex disorders.

Scitodate

Pre Seed Round in 2017
Scitodate is a developer of a scientific data recommendation platform that aims to streamline the research process for scientists by providing tailored articles efficiently. Utilizing advanced artificial intelligence and big data technology, the platform automatically collects and analyzes researchers' publications based on their registered names to create personalized research profiles. This service offers users a curated selection of new articles daily, helping them stay updated with minimal effort. Additionally, Scitodate assists organizations in gaining clear and direct data-driven market insights, while also facilitating peer reviewer selection. By focusing on these areas, Scitodate enhances the ability of researchers and decision-makers to navigate the complexities of scientific literature and make informed choices that drive growth and innovation.

Aiir Innovations

Pre Seed Round in 2016
Aiir Innovations B.V., founded in 2016 and based in Amsterdam, specializes in developing software solutions that enhance industrial processes through artificial intelligence and computer vision. The company focuses on automating borescope inspection analysis, which significantly improves the efficiency and quality of visual inspections in the aviation sector. Their software analyzes video footage and images to assist inspection teams, enabling them to identify anomalies such as cracks and dents in aircraft engines. This automation allows mechanics to concentrate on assessing damage rather than the inspection process itself, ultimately contributing to safer aircraft operations. Aiir Innovations aims to broaden the application of its technology beyond aviation, enhancing maintenance practices across various industries.

NBT Analytics

Pre Seed Round in 2016
NBT Analytics specializes in providing detailed biomedical analysis services focused on the effects of drugs on brain activity, particularly through the use of electroencephalography (EEG). The company offers a wide range of EEG biomarkers and identifies drug-specific indices, enhancing the understanding of how various interventions impact brain function. By analyzing biomarkers from both temporal and spatial perspectives, NBT Analytics enables researchers to gain comprehensive insights that are crucial for developing personalized medicine in drug development. This approach supports clinical trials by delivering statistical insights that inform the efficacy and safety of new therapeutic interventions.

Panoptes Heritage

Pre Seed Round in 2015
Panoptes Heritage specializes in bridging the gap between cultural heritage and advanced 3D technology. The company offers a range of services including 3D scanning, reconstructions, and visualizations, aimed at enhancing the conservation, documentation, and presentation of heritage sites and artifacts. With a team of heritage professionals, Panoptes Heritage utilizes the latest techniques to ensure accurate and comprehensive representations of cultural assets, thereby supporting research and public engagement in heritage preservation.

Omnigen

Pre Seed Round in 2015
Omnigen is a company that offers DNA-analysis services. The company provides biomarker discovery services, clinical studies, clinical decision-making tools, genetic analysis, and big data analysis.

Hep-Art Medical Devices

Pre Seed Round in 2015
Hep-Art Medical Devices B.V. is a spin off company of the Academic Medical Center in Amsterdam. The company has developed a robust bio-artificial liver system, the AMC-BAL. The AMC-BAL has been developed to support acute liver failure (ALF) patients to liver recovery or to the moment of donor-liver availability. The AMC-BAL is an extracorporeal supportive device that treats the plasma of the patients and temporarily replaces liver functions. The core of the system is a bioreactor that is loaded with embedded liver cells (hepatocytes). When based on porcine liver cells, the system appeared safe during a first clinical phase 1 study with ALF patients.

Digi.Bio

Pre Seed Round in 2015
Digi.Bio is a Netherlands-based company that specializes in developing software solutions for the healthcare industry, particularly in the field of cell therapies. It offers a microfluidic platform that automates repetitive and manual laboratory workflows, utilizing artificial intelligence and electrowetting technology to manipulate droplets at a microscale. This innovative approach aims to streamline multistep liquid handling applications, replacing traditional pipetting methods. Digi.Bio's platform delivers comprehensive analysis of cell therapies, evaluating their performance and outcomes at the single-cell level within 24 hours, while minimizing material waste. By enhancing automation in medical and pharmaceutical settings, Digi.Bio supports the advancement of bioengineering processes.

Enpicom

Pre Seed Round in 2015
Enpicom is a bioinformatics software company that specializes in supporting scientists in the biopharma and academic research sectors. The company offers innovative products and tailored solutions aimed at enhancing the discovery and development of new immunotherapies and vaccines. Enpicom's technology-agnostic, code-free software simplifies the management and analysis of immune repertoire sequencing data, allowing researchers to efficiently decode the immune system. By streamlining the antibody discovery process, Enpicom enables scientists to concentrate on their research and development efforts, ultimately contributing to advancements in human health.

NICO.LAB

Pre Seed Round in 2014
Born from the MRCLEAN trial, NICO.LAB was founded in 2015 as a spin-off from the Amsterdam University Medical Center. Our research background continues to drive our way of thinking. The team consists of researchers, developers and experienced medical specialists to ensure we align with our clients needs. We believe connecting human & artificial intelligence will revolutionize emergency care. Our cloud-based solution, StrokeViewer, automatically analyses brain CT scans and gives results within minutes. StrokeViewer empowers physicians in the emergency setting to provide patients with the right treatment in time.

InCatT

Pre Seed Round in 2014
InCatT B.V., or Innovative Catalyst Technologies, is a spin-off from the homogeneous catalysis group led by Prof. Dr. Joost Reek at the University of Amsterdam. The company operates as a contract research organization specializing in catalyst development for various chemical processes. InCatT focuses on enhancing catalytic processes through high throughput screening, catalyst optimization, and scale-up studies. It offers a selection of ligands, including UreaPhos and MetamorPhos, designed for asymmetric catalysis. By providing innovative solutions, InCatT assists clients in addressing catalyst challenges across multiple sectors, including pharmaceuticals, flavor and fragrance, oil and gas, and fine chemicals.

Haermonics

Pre Seed Round in 2014
Haermonics specializes in flush therapy solutions aimed at enhancing surgical outcomes, particularly in the context of open-heart procedures. The company has developed innovative postoperative surgical drainage technology that employs a warm saline mixture to effectively flush and drain the pericardial space, thereby mitigating bleeding during surgery. This approach not only improves the safety of surgical interventions but also minimizes the need for blood transfusions, ultimately leading to reduced medical expenses. By integrating its versatile therapy solutions into the surgical environment, Haermonics addresses critical challenges related to surgical blood loss and wound healing.

Illi Engineering

Pre Seed Round in 2014
Illi Engineering is a company focused on designing and developing innovative technical products, particularly aimed at improving the quality of life for elderly individuals with dementia. They create interactive technology solutions that include a customized collection of videos, music, and photos, allowing patients to access memories and evoke a sense of familiarity through recognizable images and sounds. With extensive expertise in sensor and fabrication technology, Illi Engineering combines their technical capabilities with a commitment to enhancing the well-being of their users.

Confocal.nl

Pre Seed Round in 2014
Confocal.nl is aiming to innovate the microscopy industry with their plug-and-play feature confocal microscopes including the re-scan invention (Re-scan Confocal Microscope). Their new RCM-microscope has an improved resolution and strongly improved sensitivity as compared to most confocal microscopes. It will be available as a highly affordable, customised device, which is ideal for labs with specific interests, or as an upgrade for existing wide-field fluorescence microscopes. Their goal is an open-architecture system that can be customised at need, and is platform- and software independent.

LUMICKS

Pre Seed Round in 2014
LUMICKS specializes in advanced technologies for studying biology and cancer at the single-molecule and single-cell levels. The company focuses on bridging the gap between molecular structure and function, providing tools that enable real-time analysis of complex biological processes. Its flagship product, the C-Trap Optical Tweezers, combined with Fluorescence Microscopy, allows scientists to observe interactions at the single-molecule level. Additionally, the z-Movi Cell Avidity Analyzer measures and selects immune cells based on their real-time interactions with target cells. By facilitating live measurement and imaging, LUMICKS' instruments provide critical insights into the fundamental causes of diseases, including cancer, and hold potential for optimizing drug development.

Scyfer

Pre Seed Round in 2014
Scyfer is a spin off of the University of Amsterdam specialised in machine learning solutions. As an artificial intelligence company we are partners in making intelligent software work for your company. We do that by enabling you to teach AI to work with you. From steel industry to finance, medicine and more, Scyfer brings to life innovations with impact on the bottom line. We build the bridge between academic research and state-of-the-art technology used in business.

Metrica Sports

Pre Seed Round in 2014
Metrica, was born from the desire to provide clubs with the necessary tools to transform raw data into an actionable output. At Metrica they strongly believe that the only way to get the best out of a data set, is by working side by side with managers and coaches in order to develop tailor made analysis that fit to the unique needs of a team.

904Labs

Pre Seed Round in 2014
904Labs specializes in developing a self-learning e-commerce search engine that enhances the search experience for customers while minimizing the need for ongoing maintenance. Utilizing advanced artificial intelligence and machine learning algorithms, the platform adapts to user behavior in real time, allowing it to deliver relevant search results without manual optimization. By tracking user interactions and understanding the intent behind searches, 904Labs' solution automates and streamlines the search process, making it more efficient. The company leverages years of scientific research in artificial intelligence to create a product that simplifies the search experience for users, ultimately saving businesses time and money.

Plantics

Pre Seed Round in 2014
Plantics is a manufacturer of biodegradable materials designed to address the global challenge of plastic pollution. The company develops innovative bio-plastic solutions that serve as alternatives to traditional agricultural plastic products. These materials are crafted from pure renewable resources, ensuring non-toxicity and offering properties such as flame retardancy and resistance to chemicals and heat. By providing ready-made home furnishing products, Plantics enables businesses to reduce time, labor, and waste-management costs while promoting sustainability in their operations. The company's approach emphasizes both environmental responsibility and commercial viability, aiming for a significant impact in reducing plastic waste.

Quantis

Pre Seed Round in 2014
Quantis are guide top organizations to define, shape and implement intelligent environmental sustainability solutions. They deliver resilient strategies, robust metrics, useful tools, and credible communications. In a nutshell, they’re the creative geeks. Their clients trust us to take the latest science and make it actionable. They are Quantis: sustainability’s scientists, experts, strategists, innovators and visionaries.

241 Software Solutions

Pre Seed Round in 2014
Trips is the creator of an educational application designed to provide educational institutions with a fresh perspective on how their organization operates. The company's educational application collects improved feedback and completes school results, analyzes teachers to aid in self-reflection, provides a platform for constructive conversations, and facilitates the scheduling of appointments, allowing educational institutions to digitize and improve learning processes.

Radically Open Security

Pre Seed Round in 2014
Radically Open Security is a not-for-profit computer security consulting firm. That provides cryptographic analysis, DdoS testing, code audits, and malware reversing and analysis services. They also provide network monitoring and threat detection services.

3DUniversum

Pre Seed Round in 2014
3DUniversum specializes in advanced AI technology derived from leading academic research, focusing on three-dimensional (3D) scanning, deepfake, synthetic media, image enhancement, and artificial human creation. The company develops software for 3D scanning, analysis, and printing, targeting the healthcare, media, and entertainment sectors. Utilizing deep learning, computer vision, and machine learning, 3DUniversum creates tailored solutions that enhance product sizing, defect detection, and communication for industries such as healthcare, industrial inspection, and retail. Through its innovative offerings, 3DUniversum aims to improve operational efficiency and user interaction across various applications.

Innoseis

Pre Seed Round in 2013
Innoseis develops revolutionary sensor technology.

CTcue

Pre Seed Round in 2013
Using intuitive search fields, CTcue instantly matches patients and trials based on both structured and unstructured patient data. No complex query design or involving data experts; everyone can now find eligible patients using normal language and just a few mouse clicks. Their matching algorithm will continue to search as patient data gets updated and can alert your medical team in advance and during a consult, thus increasing trial inclusion awareness. You won't miss a patient-trial match, while saving tremendous time and effort. When patients request to participate in trials, an overview is instantly available.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.